Paris, France
June 27 - June 28, 2008
NB. Auditorium room capacity is limited for this event, respecting safety guidelines. Preference will be given to early registrations.
The aim of this symposium is to present the current state-of the-art in diagnosis as well as therapy of endocrine and cardio-metabolic disorders in a highly scientific environment.
The limited number of attendees (an international audience of 100-120 participants) can be continuously updated on synergies among endocrine, cardiovascular and metabolic disorders over the next couple of years.
LEARNING OBJECTIVES
After participating in this symposium, the participants will have been updated regarding the integrated disease management approach and knowledge in:
- Synergies between cardiovascular manifestation and endocrine disorders
- Metabolic complications in endocrine disorders
- Management update of endocrine and metabolic disorders
In particular cardiovascular manifestations will be evaluated in patients presenting thyroid disorders, diabetic patients, pediatric and adult growth hormone deficiency.
TARGET AUDIENCE
Clinicians (endocrinologists and paediatric endocrinologists, diabetologists, cardiologists) experts in genetics, epidemiologists interested in interdisciplinary disease management will benefit from this symposium.
Serono Symposia International Foundation (www.seronosymposia.org) has submitted this program “Integrated Approach to Disease Management: Endocrinology and Cardio-Metabolic Disorders” (Paris, France, 27-28 June 2008) for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME), and by the Italian Ministry of Health (ref. n. 10565-8024831).
